Ascend Wellness Holdings LLC Class A

Ascend Wellness Holdings LLC Class A

0.35
USD
-0.01
(-4.17%)
-0.57EPS
107.65MMarket Cap
Mar 16Next Earn
Ascend Wellness Holdings LLC Class A
CSE:AAWH.U
(Canadian Securities Exchange)

Recent

price

0.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
USD
0.07
0.86
2.22
2.21
2.6
2.64
2.46
2.44
Revenue per Share
-0.19
-0.15
-0.82
-0.44
-0.24
-0.4
-0.58
-0.57
Basic EPS, GAAP
-0.61
-0.19
-0.87
-0.9
0.18
0.18
- -
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.02
1.03
0.87
0.69
0.35
-0.23
-0.56
Book Value per Share
- -
-0.41
0.43
-0.54
-0.61
-0.9
-1.49
-1.85
Tangible Book Value per Share
168
168
149
183
199
212
203
203
Basic Weighted Avg Shares
12
144
332
406
519
562
501
494
Sales/Revenue/Turnover
-217.1
5.66
5.99
-0.54
-0.74
0.85
-0.15
2.27
Operating Margin (%)
4
13
24
38
60
68
76
83
Depreciation Expense
-32
-25
-123
-81
-48
-85
-118
-116
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-265.08
-17.7
-36.9
-19.93
-9.3
-15.13
-23.61
-23.49
Profit Margin (%)
- -
19
141
88
136
85
100
65
Working Capital
- -
309
428
549
559
502
614
626
LT Debt
- -
4
176
163
143
72
-47
-112
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-136.09
-47.6
-31.48
-79.49
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
16
32
36
LT Borrowings
292
294
295
LT Finance Leases
323
330
331
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
203
203
203
Market Capitalization
91
104
108

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
189
187
181
Cash, Cash Equivalents & STI
61
67
64
Accounts Receivable, Net
26
26
25
Inventories
87
82
83
Total Current Liabilities
88
113
116
Payables & Accruals
64
71
71
ST Debt
16
32
36
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
865.33%
-164.93%
Free Cash Flow
- -
22.65%
-99.75%
Net Income, GAAP
- -
84.61%
39.06%
Sales/Revenue/Turnover
- -
35.71%
-10.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
142
142
142
136
562
2025
128
127
125
121
501
2026
117
126
130
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.09
-0.1
-0.13
-0.08
-0.4
2025
-0.09
-0.12
-0.13
-0.24
-0.58
2026
-0.15
-0.05
-0.14
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Ascend Wellness Holdings, Inc. is a vertically integrated cannabis company engaged in the cultivation, production, distribution, and retailing of cannabis products across the United States. The company’s core products include cannabis flower, pre-rolls, concentrates, vaporizer cartridges, capsules, tinctures, edibles, and topicals. Ascend operates seven state-of-the-art cultivation facilities and a retail network consisting of 46 dispensaries nationwide, serving key markets such as Illinois, Massachusetts, New Jersey, and Ohio. Founded in 2018 and headquartered in New York City, Ascend Wellness Holdings targets adult-use and medical cannabis consumers, focusing on premium, award-winning strains and curated product selections. In terms of recent developments, Ascend Wellness has expanded its retail footprint with seven new stores added in 2025 alone, and aims to grow its store count by approximately 50% with an additional 20 locations projected in the midterm. The company launched a fully refreshed eCommerce platform featuring the Ascenders Club, a four-tiered loyalty program designed to enhance customer engagement through personalized rewards and benefits. In 2025, Ascend introduced the new brand "Effin" which has performed strongly in edibles and launched the Ethn brand focused on targeted effects, now a top-selling edible brand in its stores. The company also completed a $50 million private placement of senior secured notes and successfully refinanced a $60 million term loan to strengthen its balance sheet, alongside executing an 11 million share buyback representing 5% of its outstanding shares. Operational strategies have focused on margin optimization with a 24.9% adjusted EBITDA margin achieved in Q3 2025 and a 300 basis point sequential increase in adjusted gross margin, supporting sustainable growth and profitability goals. Ascend maintains a robust cash position to fund continued strategic expansion and innovation across its vertically integrated cannabis operations.

Company News

  • Ascend Wellness Q3 Earnings Call Highlights

  • Ascend Wellness Holdings, Inc. (AAWH) Q3 2026 Earnings Call Transcript

  • Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Tops Revenue Estimates

  • AWH Reports Third Quarter 2026 Financial Results

  • Ascend Wellness Holdings Closes $11 Million Non-Dilutive Mortgage Loan on Five Properties Across Three States

  • AWH to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 12, 2026

  • Ascend Wellness Holdings Launches Effin' Tabs, a New Line of Precision-Dosed THC Tablets

  • Ascend Wellness Holdings Announces the Opening of Ascend of Evesham Dispensary in Marlton, New Jersey

  • Analyzing Chugai Pharmaceutical (OTCMKTS:CHGCY) & Ascend Wellness (OTCMKTS:AAWH)

  • Ascend Wellness Holdings Announces the Opening of New Dispensary in Lewis Center, Ohio

  • AWH Stockholders Approve Reverse Stock Split, a Prerequisite to a U.S. Exchange Listing

  • Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript

  • Ascend Wellness Q2 Earnings Call Highlights

  • Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Beats Revenue Estimates

  • Ascend Wellness Holdings, Inc. (AAWH) Q2 2026 Earnings Call Transcript

  • AWH Reports Second Quarter 2026 Financial Results

  • AWH Reminds Stockholders to Vote on Reverse Stock Split for August 28 Special Meeting

  • AWH to Hold Second Quarter 2026 Earnings Conference Call on Wednesday, August 12, 2026

  • AWH Announces Reverse Stock Split Vote in Support of Planned U.S. Exchange Uplisting

  • AWH Files DEA Registration Applications for State-Licensed Medical Cannabis Operations